Key Highlights

● AXON closed at $422.89 on 9 October 2026, and the $721.57 consensus target implies upside of about 70.6 per cent on paper.

● The consensus draws on 17 analysts, with targets from $600 to $825.

● Market data shows 15 Buy ratings (including one Strong Buy), two Hold and no Sell, a Moderate Buy consensus.

● After results on 6 August, Barclays raised its target to $688 from $523 and UBS to $600 from $440, among other increases.

Axon Enterprise, Inc. (NASDAQ:AXON) is a public-safety technology company known for TASER devices, body cameras and cloud software. The last close in the data was $422.89 on 9 October 2026, with the consensus analyst target about 70.6 per cent higher.

What Is the Latest Analyst Price Target?

The consensus (mean) price target is $721.57, based on 17 analysts with ratings in the previous twelve months. The data is dated 9 October 2026. The range runs from a low of $600.00 to a high of $825.00. Compared with the $422.89 price, the consensus target suggests potential upside of about 70.6 per cent.

What Are Wall Street Analysts Saying?

The rating split is 15 Buy (incl. 1 Strong Buy), 2 Hold, 0 Sell (market data consensus: Moderate Buy). After results on 6 August 2026, Morgan Stanley (Meta Marshall) lifted its target to $640 from $600, Piper Sandler (James Fish) to $732 from $724, Barclays (Tim Long) to $688 from $523 and UBS (Andrew Spinola) to $600 from $440 with a Neutral rating; Goldman Sachs (Michael Ng) reiterated Buy with a $715 target. Argus (John Staszak) raised to $600 from $460 on 3 September, and Citizens JMP held a $700 target in June. JPMorgan (Joseph Cardoso) raised to $755 from $750 in May. An independent ratings service upgraded the shares on 5 October.

What Could Help the Stock Reach the Price Target?

For the shares to move towards the consensus target, analysts would be looking for continued growth in recurring software and cloud revenue, new product adoption and strong execution, which analysts cited when lifting targets in August. Every published target is at least $600, well above the last close.

What Could Prevent the Stock Reaching the Target?

The main risks include the very wide gap between the price and the consensus target, which is roughly 71 per cent above the last close. A gap that large can indicate that estimates have not caught up with a lower share price, or that the market is questioning growth and valuation assumptions. Many of the target changes date from August, so they may be stale. Share prices can also be affected by broader market conditions, interest rates and company-specific news that analysts did not anticipate.

What Should Investors Watch Next?

The next quarterly results are the most obvious catalyst, as they usually prompt analysts to revise ratings and targets. Other things to watch include further broker target changes, management guidance and sector-wide data.

Axon's Every Target Sits at $600 or Above, Far From the Last Close

Axon closed at $422.89 on 9 October 2026, and every published target is at least $600, with the $721.57 consensus about 70.6 per cent above the close. A gap that large can indicate that estimates have not caught up with a lower share price, or that the market is questioning growth and valuation assumptions, and many of the target changes date from August, after results on 6 August. Ratings are strongly positive, with no Sell, and the August increases from Barclays, UBS, Morgan Stanley and Piper Sandler centred on continued growth in recurring software and cloud revenue.